banners

EVALUATION OF EFFECTIVENESS, SAFETY AND ECONOMY OF MEDICINES



This research group specialises in the evaluation of drug efficacy, safety and cost. In this multidisciplinary group you can find experts in digestive diseases, primary care physicians, clinical pharmacologists and health economists. They belong to the Málaga Biomedical Research Institute (IBIMA), University of Malaga, Andalusian Public Healthcare System and Center for Biomedical Network Research: hepatic and digestive diseases (CIBERehd). It is also a mentoring centre for the IUPHAR (International Union of Basic and Clinical Pharmacology; https://iuphar.org/clinical-division/mentoring-centers/) clinical pharmacology programme.



Research Topics

  • Study of Drug-Induced Liver Injury: pharmacoepidemiology, risk factors, patient risk stratification, outcome.
  • Mechanisms of Drug-Induced Liver Injury: genetic, exosomes, microRNAs, epigenetics, metabolics, microbiota and inmunophenotyping studies.
  • Steatohepatitis and hepatotoxicity: biomarkers.
  • Health economics and rational use of drugs.
  • Drug safety and efficacy in primary care.

 

Scientific-Technical Services

  • Liver safety assessment for drugs (Spain, Latin-America and European Union).
  • Fatty liver and drug use evaluation.
  • Design and evaluation in clinical trials. Stopping rules. Monitoring and Pharmacovigilance.
  • Biomarkers qualification and development.
  • Health Economics consulting.
EVALUATION OF EFFECTIVENESS, SAFETY AND ECONOMY OF MEDICINES

 

Contact


Main Researcher: Mª ISABEL LUCENA GONZALEZ

PAI Reference: CTS649

Web: www.spanishdili.uma.es

Contact

Before content body
Chunks
Chunks
News and Standingouts slideshow
After content body